Table 1. Epidemiological and clinical characteristics of confirmed COVID-19 patients.
Characteristics | Total (N=159) | Nonsevere (N=101) | Severe (N=58) | P value |
---|---|---|---|---|
Age, median [IQR], years | 53 [37–63] | 47 [34–58] | 63 [54–66] | 0.001 |
Sex, No. (%) | ||||
Male | 82 (51.6) | 39 (38.6) | 43 (74.1) | 0.000 |
Female | 77 (48.4) | 62 (61.4) | 15 (25.9) | |
Exposure History within 2 weeks, No. (%) | ||||
Wuhan travel history | 129 (81.1) | 87 (86.1) | 42 (72.4) | 0.033 |
Contact with suspected patient | 25 (15.7) | 12 (11.9) | 13 (22.4) | 0.079 |
Contact with confirmed patient | 36 (22.6) | 28 (27.7) | 9 (15.7) | 0.049 |
Signs and symptoms, No. (%) | ||||
Fever | 115 (72.3) | 63 (62.4) | 52 (89.7) | 0.000 |
Dry cough | 62 (39.0) | 33 (32.7) | 29 (50.0) | 0.031 |
Myalgia | 12 (7.5) | 9 (8.9) | 3 (5.2) | 0.584 |
Pharyngalgia | 12 (7.5) | 10 (9.9) | 2 (3.4) | 0.242 |
Dyspnea | 10 (6.3) | 5 (5.0) | 5 (8.6) | 0.563 |
Fatigue | 9 (5.7) | 5 (5.0) | 4 (6.9) | 0.877 |
Diarrhea | 7 (4.4) | 3 (3.0) | 4 (6.9) | 0.259 |
Stuffy or runny nose | 5 (3.1) | 2 (2.0) | 3 (5.2) | 0.355 |
Headache or dizziness | 4 (2.5) | 1 (1.0) | 3 (5.2) | 0.138 |
Nausea or vomiting | 2 (1.3) | 2 (2.0) | 0 (0.0) | 0.534 |
Chills | 1 (0.6) | 0 (0.0) | 1 (1.7) | 0.365 |
Comorbidity, No. (%) | ||||
Hypertension | 21 (13.2) | 10 (9.9) | 11 (19.0) | 0.104 |
Diabetes | 7 (4.4) | 6 (5.9) | 1 (1.7) | 0.424 |
Cardiovascular disease | 6 (3.8) | 4 (4.0) | 2 (3.4) | 0.618 |
Cancer | 1 (0.6) | 0 (0.0) | 1 (1.7) | 0.365 |
Other | 15 (9.4) | 6 (5.9) | 9 (15.5) | 0.087 |
COVID-19, coronavirus disease 2019. IQR, interquartile range.